4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000403
Chief Financial Officer sold 9,022 shares at an average $526.49 ($4,749,990)
- Chief Financial Officer acquired 9,022 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hippel James · Chief Financial Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-11-01 | Exercise or conversion : show line 1 in the form | +8,822 | $125.05 | $1,103,191 | 19,577 | D |
| 2021-11-01 | Sale : show line 2 in the form | −3,566 | $525.61 | $1,874,318 | 16,011 | D |
| 2021-11-01 | Sale : show line 3 in the form | −2,880 | $526.50 | $1,516,321 | 13,131 | D |
| 2021-11-01 | Sale : show line 4 in the form | −1,433 | $527.50 | $755,903 | 11,698 | D |
| 2021-11-01 | Sale : show line 5 in the form | −943 | $528.55 | $498,427 | 10,755 | D |
| 2021-11-02 | Exercise or conversion : show line 6 in the form | +200 | $125.05 | $25,010 | 10,955 | D |
| 2021-11-02 | Sale : show line 7 in the form | −200 | $525.10 | $105,020 | 10,755 | D |
| Open-market sales · 9,022 sh · avg $526.49 · $4,749,990 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-01 | Exercise or conversion : show line 8 in the form Stock Options (Right to Buy) | −8,822 | 47,589 | D |
| 2021-11-02 | Exercise or conversion : show line 9 in the form Stock Options (Right to Buy) | −200 | 47,389 | D |
Loading xslF345X03/edgar.xml…